Stay updated on Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page
- ChecktodayChange DetectedA new revision tag was added, updating the page from Revision: v3.6.3 to Revision: v3.6.4, indicating a newer edition of the study record metadata.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew update dates were added (2026-07-07, 2026-06-16, 2026-06) and older dates were removed (2025-06-08, 2025-05-28, 2025-05), reflecting routine maintenance of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a platform update. The study details, eligibility criteria, and other content remain unchanged in this update.SummaryDifference0.0%

- Check43 days agoChange DetectedRecruitment status on the study page is updated to 'No longer looking for participants', indicating the study is not enrolling new participants. The page also adds new help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and changes the label from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page now includes a Revision: v3.5.5 tag, replacing the previous Revision: v3.5.4. This indicates the page record has been updated to version 3.5.5.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.